Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart DiseaseClarke E. Atkins, Rebecca L. Stepien, John D. Bonagura et al.|Journal of Veterinary Internal Medicine|2009Cited by 545
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical TrialAdrian Boswood, Philip Watson, Bruce W. Keene et al.|Journal of Veterinary Internal Medicine|2016Cited by 318
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL StudyPhilip R. Fox, Marie de Swarte, Bruce W. Keene et al.|Journal of Veterinary Internal Medicine|2018Cited by 152
Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: The PREDICT cohort studyCaryn Reynolds, Mark A. Oyama, Dorothy Cimino Brown et al.|Journal of Veterinary Cardiology|2012Cited by 126
Multicenter Evaluation of Plasma N-Terminal Probrain Natriuretic Peptide (NT-pro BNP) as a Biochemical Screening Test for Asymptomatic (occult) Cardiomyopathy in CatsPhilip R. Fox, Mark A. Oyama, John E. Rush et al.|Journal of Veterinary Internal Medicine|2011Cited by 100